ITL News & Events

ITL Wins SSK Contract Extension with US Blood Bank

ITL BioMedical, a division of ITL Health Group (ASX:ITD), that sets industry standards for the innovative design and production of biological sampling systems, is pleased to announce a contract extension of 12 months with a large US community blood bank for its SampLok® Sampling Kit (“SSK”). ITL BioMedical has been a supplier to this blood center for over four years.

Read More “ITL Wins SSK Contract Extension with US Blood Bank” »

MyHealthTest Achieves Major Milestone of Laboratory Accreditation

MyHealthTest (MHT), a division of ITL Health Group (ASX:ITD) that creates and markets highly innovative direct to consumer pathology testing for major chronic diseases, is very pleased to announce it has been granted accreditation for its testing laboratory to the ISO15189 and NPAAC (National Pathology Accreditation Advisory Council) standards by the National Association of Testing Authorities (NATA) and the Royal College of Pathologists of Australasia (RCPA).

Read More “MyHealthTest Achieves Major Milestone of Laboratory Accreditation” »

1 2